Légende
: Essai en cours de recrutement = 
; Essai en cours = 
-
- ALLEMAGNE
- Baden-Württemberg
- HEIDELBERG
- SAHA-I: A Phase II Study to investigate the efficacy and tolerability of Vorinostat in patients suffering from advanced, metastatic Soft Tissue Sarcoma
- Universitätsklinikum Heidelberg
- Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie
- Plus de détails
-
- ALLEMAGNE
- Baden-Württemberg
- STUTTGART
- EURO-B.O.S.S.: A European treatment protocol for bone sarcoma in patients older than 40 years - DE
- Klinikum Stuttgart, Standort Olgahospital
- COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale
- Plus de détails
-
- EORTC 62961: Phase III randomized study of neoadjuvant Etoposide, Ifosfamide, and Doxorubicin with or without regional hyperthermia in patients with high-risk soft tissue sarcoma - Terminated
- LMU Klinikum der Universität München - Campus Großhadern
- Medizinische Klinik und Poliklinik III
- Plus de détails
-
- ALLEMAGNE
- Niedersachsen
- HANNOVER
- EPAZ: A randomized phase II trial comparing Pazopanib with Doxorubicin as first line treatment in elderly patients with metastatic or advanced Soft Tissue Sarcoma
- Medizinische Hochschule Hannover
- Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
- Plus de détails
-
- ALLEMAGNE
- Nordrhein-Westfalen
- KÖLN
- EORTC 62072 (PALETTE) - A randomized, double blind phase III trial of Pazopanib versus Placebo in patients with Soft Tissue Sarcoma whose disease has progressed during or following prior therapy - DE
- Universitätsklinikum Köln
- Klinik I für Innere Medizin - AG Prof. Wendtner
- Plus de détails
-
- ALLEMAGNE
- Nordrhein-Westfalen
- KÖLN
- PICASSO III: A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of Doxorubicin plus Palifosfamide-tris versus Doxorubicin plus Placebo in patients with front-line metastatic Soft Tissue Sarcoma - DE
- Universitätsklinikum Köln
- Klinik I für Innere Medizin - AG Prof. Wendtner
- Plus de détails
-
- ALLEMAGNE
- Nordrhein-Westfalen
- MÜNSTER
- EPOC-MS-001: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE
- Universitätsklinikum Münster
- AG Prof. Boos: Experimentelle pädiatrische Onkologie
- Plus de détails
-
- ALLEMAGNE
- Sachsen
- DRESDEN
- A randomized, open-label, multicenter, phase III study to compare the efficacy and safety of Eribulin with Dacarbazine in subjects with Soft tissue sarcoma - DE
- Universitätsklinikum Carl Gustav Carus an der TU Dresden
- Medizinische Klinik und Poliklinik I
- Plus de détails
-
- ALLEMAGNE
- Schleswig-Holstein
- KIEL
- A Phase II Trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor for the treatment of patients with recurrent or refractory Ewing's Sarcoma, recurrent or refractory Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and other Sarcomas
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
- Krebszentrum Nord
- Plus de détails
-
- ALLEMAGNE
- Schleswig-Holstein
- KIEL
- Randomized Phase II Trial of Trofosfamide vs. Adriamycin in elderly patients with previously untreated metastatic Soft Tissue Sarcoma
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
- Krebszentrum Nord
- Plus de détails
-
- ESPAGNE
- Baleares
- PALMA DE MALLORCA
- Randomized, open, multicenter, prospective, Phase II clinical trial of Doxorubicin vs. Trabectedin plus Doxorubicin in the first line treatment of patients with advanced non operable and/or metastatic soft tissue sarcomas
- Hospital Universitario Son Espases
- Telecomité de Tumores Musculoesqueléticos (COTMES)
- Plus de détails
-
- ESPAGNE
- Cataluña
- BARCELONA
- Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas (Phase III)
- Hospital Universitari Vall d'Hebron. Area Materno Infantil
- Servicio de Hematología y Oncología Pediátrica
- Plus de détails
-
- ESPAGNE
- Cataluña
- BARCELONA
- A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously- Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET (Peripheral Neuroectodermal Tumor) - ES (completed)
- Hospital de la Santa Creu i Sant Pau
- Servicio de Oncología Médica (H. de la Santa Creu i Sant Pau)
- Plus de détails
-
- ESPAGNE
- Cataluña
- L'HOSPITALET DE LLOBREGAT
- A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously- Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET (Peripheral Neuroectodermal Tumor) - ES (completed)
- ICO L'Hospitalet
- Servicio de Oncología Médica (ICO L'Hospitalet)
- Plus de détails
-
- ESPAGNE
- Cataluña
- L'HOSPITALET DE LLOBREGAT
- Phase I-II, Not-Randomized, Multicenter Clinical Trial to Evaluate Safety and Efficacy of Sorafenib (BAY-43-9006) in Combination With Ifosfamide in Soft Tissue Sarcoma
- ICO L'Hospitalet
- Servicio de Oncología Médica (ICO L'Hospitalet)
- Plus de détails
-
- ESPAGNE
- Cataluña
- L'HOSPITALET DE LLOBREGAT
- Phase II Study of Neoadyuvant High-dose Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma and Identification of Response Predictors (completed)
- ICO L'Hospitalet
- Servicio de Oncología Médica (ICO L'Hospitalet)
- Plus de détails
-
- ESPAGNE
- Cataluña
- L'HOSPITALET DE LLOBREGAT
- A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination With Doxorubicin vs. Doxorubicin Alone in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma - ES
- ICO L'Hospitalet
- Servicio de Oncología Médica (ICO L'Hospitalet)
- Plus de détails
-
- ESPAGNE
- Comunidad Valenciana
- VALENCIA
- Randomized, open, multicenter, prospective, Phase II clinical trial of Doxorubicin vs. Trabectedin plus Doxorubicin in the first line treatment of patients with advanced non operable and/or metastatic soft tissue sarcomas
- Fundación Instituto Valenciano de Oncología
- Servicio de Oncología Médica (IVO)
- Plus de détails
-
- TRUSTS: A Phase IIB/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma - ES
- Hospital Clínico San Carlos
- Servicio de Oncología Médica (H.C. San Carlos)
- Plus de détails
-
- ESPAGNE
- Madrid
- MAJADAHONDA
- PICASSO III: A Phase III Multicenter, International, Randomized, Double-blind, Placebo-controlled Study of Doxorubicin Plus Palifosfamide-tris vs. Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma
- Hospital Universitario Puerta de Hierro
- Servicio de Oncología Médica (H. Puerta del Hierro)
- Plus de détails
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- A Multinational, Randomized, Double-Blind Placebo Controlled Study of AVE8062 (25 mg/m2) Administered Every 3 Weeks in Patients With Advanced-Stage Soft Tissue Sarcoma, Treated With Cisplatin (75 mg) After Failure of Anthracycline and Ifosfamide Chemotherapies (Phase II-III)
- Not yet identified - ES
- Plus de détails
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- PALETTE: A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy (completed)
- Not yet identified - ES
- Plus de détails
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- A Randomized, Multicenter, Phase III Trial of Trabectedin (Yondelis) Versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients With Translocation-Related Sarcomas (TRS) - ES (Prematurely Ended)
- Not yet identified - ES
- Plus de détails
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- Multicenter, prospective, open-label, uncontrolled study in patients aged 45 years or older to evaluate the efficacy and safety of Liposomal Doxorubicin (Doxorubicin GP-Pharm) in first-line treatment in soft-tissue sarcomas (Phase I-II) - ES
- Not yet identified - ES
- Plus de détails
-
- ESPAGNE
- Madrid
- NOT YET IDENTIFIED - ES
- A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma - ES
- Not yet identified - ES
- Plus de détails
-
- FRANCE
- ILE-DE-FRANCE
- VILLEJUIF
- LMS02 : Etude de phase II multicentrique étudiant l'efficacité de la doxorubicine associée à de la trabectedine (Yondelis) en première ligne dans le traitement des patients présentant un léiomyosarcome métastatique (utérin ou des tissus mous) et/ou en rechute inopérable.
- CRLCC Institut de cancérologie Gustave Roussy
- Service Gynécologie
- Plus de détails
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Etude de phase III randomisée comparant la doxorubicine versus l'association doxorubicine plus ifosfamide dans le traitement des sarcomes des tissus mous de l'adulte en phase avancée ou métastatique - Terminé -
- CHU de Marseille - Hôpital de la Timone
- Service d'oncologie médicale
- Plus de détails
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Etude pharmacocinétique de la doxorubicine en fonction de l'âge chez les enfants atteints de tumeurs solides ou de leucémies (Doxo).
- CHU de Marseille - Hôpital de la Timone
- Service d'oncologie pédiatrique
- Plus de détails
-
- Etude multicentrique, prospective, en ouvert, non contrôlée, de phase I-II, pour évaluer l'efficacité et la tolérance de la doxorubicine liposomale (Doxorubicine GP-Pharm) en traitement de première ligne des sarcomes des tissus mous chez les patient âgés de 45 ans et plus.
- CRLCC Léon Bérard
- Centre Léon Bérard
- Plus de détails
-
- ESTIM : Evaluation, chez des patients adultes atteints de sarcome avancé des tissus mous, après échec d'un traitement par Doxorubicine, de l'efficacité et de la tolérance d'un traitement trihebdomadaire par Panobinostat - LBH589 : étude ouverte, multicentrique, de phase II
- CRLCC Léon Bérard
- Centre Léon Bérard
- Plus de détails
-
- Etude multicentrique de phase I / II de sunitinib en dosage continu dans les sarcomes non-GIST avec une radiothérapie concomitante.
- CRLCC Léon Bérard
- Département de radiothérapie
- Plus de détails
-
- FRANCE
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Multicenter, prospective, open-label, uncontrolled study in patients aged 45 years or older to evaluate the efficacy and safety of Liposomal Doxorubicin (Doxorubicin GP-Pharm) in first-line treatment in soft-tissue sarcomas - FR
- Not yet identified - FR
- Plus de détails
-
- FRANCE
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Phase 1/2 Efficacy, Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood, and Subsequent Collection by Apheresis, Versus Standard Mobilisation Regimens Alone in Paediatric Patients, with Solid Tumours Eligible for Autologous Transplants - FR
- Not yet identified - FR
- Plus de détails
-
- FRANCE
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma - FR
- Not yet identified - FR
- Plus de détails
-
- FRANCE
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma - FR
- Not yet identified - FR
- Plus de détails
-
- FRANCE
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy - FR
- Not yet identified - FR
- Plus de détails
-
- ROYAUME-UNI
- Greater Manchester
- MANCHESTER
- Ifosfamide and doxorubicin, radiation therapy, and/or surgery in treating young patients with localized soft tissue sarcoma (Phase III) - UK -
- Royal Manchester Children's Hospital
- Department of Oncology
- Plus de détails
-
- ROYAUME-UNI
- Greater Manchester
- NOT YET IDENTIFIED - UK
- Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia
- NOT YET IDENTIFIED - UK
- Plus de détails
-
- ROYAUME-UNI
- South Yorkshire
- SHEFFIELD
- Axi-STS: A clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas
- Weston Park Hospital
- Cancer Clinical Trials Centre
- Plus de détails
-
- ROYAUME-UNI
- South Yorkshire
- SHEFFIELD
- EORTC 62931: Randomized phase III trial of adjuvant chemotherapy with high-dose doxorubicin, ifosfamide and lenograstim in high grade soft tissue sarcoma - UK
- Weston Park Hospital
- Cancer Clinical Trials Centre
- Plus de détails
-
- ROYAUME-UNI
- Surrey
- SUTTON
- EORTC 62012: Randomised Trial Of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide In The First Line Treatment Of Advanced Or Metastatic Soft Tissue Sarcoma (Phase III)
- The Royal Marsden Hospital
- Sarcoma Unit
- Plus de détails
